Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Sarepta Therapeutics closes on $600M credit facility

February 15, 2025 9:02 am
Sarepta Therapeutics Inc (NASDAQ: SRPT) said on Friday that it had closed on a $600 million senior secured revolving credit facility with a bank syndicate. JPMorgan Chase Bank N.A. serves as Administrative Agent and acted as Lead Arranger and Joint Bookrunner, Sarepta said. “Sarepta’s financial strength and the positive outlook for our business provide us […] Read more

Northpointe Bancshares prices Initial Public Offering at $14.50/share

February 14, 2025 12:04 pm
Northpointe Bancshares Inc, the bank holding company for Northpointe Bank, said on Thursday that it had priced its initial public offering of 10,420,000 shares of its common stock at a price to the public of $14.50 per share. The net proceeds from the offering, after deducting underwriting discounts and commissions and estimated offering expenses, are […] Read more

GoPro announces partnership with Kimpex Powersports

February 14, 2025 9:42 am
GoPro Inc (NASDAQ: GPRO) said on Thursday that it had formed a new distribution partnership with Kimpex Powersports in Canada. Under the agreement, Kimpex will be able to provide its network of over 2,300 dealers with the full range of GoPro cameras and accessories. “Partnering with GoPro marks an exciting chapter for Kimpex and our […] Read more

Ventas increases quarterly dividend to $0.48

February 14, 2025 7:56 am
Ventas Inc (NYSE: VTR) said this week its Board of Directors had authorized a quarterly cash dividend of $0.48 per share of common stock. The latter represents an increase of 6.67% compared to the previous quarterly dividend of $0.45 per share. The dividend will be paid on April 17th to shareholders of record as of […] Read more

CRISPR Therapeutics price targets raised at TD Cowen, Truist Securities, BofA

February 13, 2025 12:18 pm
The shares of CRISPR Therapeutics AG (NASDAQ: CRSP) rose more than 9% on Wednesday, after analysts at several companies raised their price targets on the CRSP stock. TD Cowen raised its 12-month price target on CRISPR Therapeutics to $35 per share from $30 previously. The firm also upgraded the stock to “Hold” from “Sell”. Truist […] Read more

Manhattan Associates Inc CEO to step down

February 11, 2025 11:36 am
Manhattan Associates Inc (NASDAQ: MANH) said on Monday that Eddie Capel, current President and CEO, would step down from his position, effective February 12th. He will remain with the company as Executive Vice-Chairman of the Board. Capel is to be succeeded by Eric Clark, who has been CEO of NTT Data North America. Capel became […] Read more

Hyatt Hotels Corp to acquire Playa Hotels & Resorts

February 11, 2025 9:48 am
Hyatt Hotels Corp (NYSE: H) said on Monday that it had entered into an agreement to acquire all outstanding shares of Playa Hotels & Resorts N.V. for nearly $2.6 billion ($13.50 per share), including about $900 million of debt, net of cash. At present, Hyatt owns 9.4% of Playa’s outstanding shares. ”Hyatt has firmly established […] Read more

Merck & Co downgraded to ”Hold” at TD Cowen

February 11, 2025 8:06 am
Merck & Company Inc (NYSE: MRK) has been downgraded to “Hold” from “Buy” at TD Cowen, as the firm cited uncertainty surrounding Gardasil sales, a slowdown in business development and the potential loss of exclusivity for cancer drug Keytruda. TD Cowen noted that Merck’s valuation would likely bottom out in 2026, or two years prior […] Read more

PotlatchDeltic announces $0.45 quarterly dividend

February 10, 2025 12:16 pm
PotlatchDeltic Corp (NASDAQ: PCH) said on Friday that its Board of Directors had authorized a quarterly cash dividend of $0.45 per share of common stock. The dividend was kept unchanged from the previous quarterly dividend payment. The dividend will be paid on March 31st to shareholders of record as of the close of business on […] Read more

Capital One Financial announces $0.60 quarterly dividend

February 10, 2025 9:23 am
Capital One Financial Corp (NYSE: COF) said on Friday that its Board of Directors had authorized a quarterly cash dividend of $0.60 per share of common stock. The dividend was kept unchanged from the previous quarterly dividend payment. The dividend will be paid on March 3rd to shareholders of record as of the close of […] Read more